DUE DATE: October 11, 2024
Access the NIAID New Innovator Award website!
The NIAID New Innovator DP2 program has been in place since 2019 to help launch research careers for talented individuals with creative, novel, high-impact research concepts that may be risky or at a stage too early to fare well in the traditional peer review process. The NIAID DP2 program supports Early-Stage Investigators (ESIs) of exceptional creativity who propose novel, original, and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NIAID. ESIs who are either non-independent (postdoc or beyond) or within the first year of an independent research position may apply. (Note this is one of the key differences from the NIH Common Fund DP2 program, which is restricted to ESIs who are already independent).
For all applicants:
- applicants must have a research or clinical doctorate (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent doctoral degree), or a combined research and clinical doctoral degree.
- both U.S. and non-U.S. citizens may apply.
- $300K in direct costs per year for up to five years may be requested.
- applicants must have Early Stage Investigator status.
For newly independent applicants:
- the applicant must be within the first year of a faculty position or equivalent at a U.S. based institution at the time of application submission.
For postdoctoral and other non-independent applicants:
- if selected for award, applicants must transition to an independent faculty position or equivalent at a U.S.-based institution within one year in order to activate the award.
Contact: Diane Lawrence, Ph.D., Program Officer, Pathogenesis and Basic Research Branch, Basic Science Program, Division of AIDS, NIAID, 5601 Fishers Lane, Rm 9G22 Bethesda, MD 20892, 240-627-3202, lawrencedi@niaid.nih.gov